Company Overview and News

 
Scooters India: Focus on revamp

15h thehindubusinessline
The government on Wednesday approved restructuring of the balance sheet of Scooters India by way of reduction of equity of ₹85.21 crore in the share capital held by the Centre against accumulated losses. The reduction would be deemed to have taken effect as on March 31, 2013, and freezing the interest on the ‘non-plan’ loan of ₹1.89 crore released to SIL during 2012-13. The move is expected to clear a hurdle in the process of disinvestment of the company.

 
GAIL, MOIL, CUB, Amrutanjan results

15h thehindubusinessline
20 Microns, Amrutanjan, Camlin Fine Sciences, Cochin Shipyard, City Union Bank, Cummins, Digjam, Elgi Rubber, GACL, GAIL India, GIPCL, Gokaldas, Granules, Honda Siel, Heldelberg, IVP, Jindal Drilling, Maharashtra Seamless, MCF, MOIL, NCC, Pidilite, Ramco Ind, Somany Ceramics, Sundaram Finance Holdings, UB, United Spirits, Xchanging and Xpro are among the 75 firms that will declare their quarter/full year results for the period ended March 2018 on Thursday.

 
Kaveri Seed: Eyes on results, buyback

15h thehindubusinessline
The board of Kaveri Seed Company will meet on Thursday to consider the audited financial results for the quarter/year ended March 31, 2018. The board will also consider a proposal for buyback of the equity shares of the company. If the proposal is approved by the board, shareholders would be keen to know the price, issue size and mode of buyback (whether open market purchase or through tender route).

 
Broker's call: Ashok Leyland (Buy)

15h thehindubusinessline
Ashok Leyland possesses a diversified product portfolio ranging from trucks, buses and LCVs to defence vehicles and power solutions. With increasing emphasis on better infrastructure by the current government and various favourable economic and policy reforms, there will be an uptick in the demand for commercial vehicles. One of the major beneficiaries of this growth will be Ashok Leyland, with pure play in the CV segment.

 
DQ Entertainment inks exclusive deal with Chiliad Procons

15h thehindubusinessline
DQ Entertainment has signed an exclusive indoor theme park deal with Chiliad Procons, an Indian leader in the amusement industry space, at the Las Vegas Licensing Show, to open multiple indoor theme parks around DQE’s IPs such as the Jungle Book, Peter Pan and Robinhood.

 
State Bank of India - Updates

17h nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.

 
SBI shares continue to gain, up nearly 4%

17h moneycontrol
Shares of State Bank of India (SBI) extended its gaining streak for the second straight session today, rising nearly 4 percent, amid positive guidance by the company. The stock gained 3.56 percent to end at Rs 263.20 on BSE. During the day, it surged 6.11 percent to Rs 269.70.

 
[email protected]: Nifty breaks below 50-DMA, next target placed at 10,350

20h moneycontrol
Equity benchmarks on Wednesday failed to cash in on positive close from the previous session as selling pressure dominated in the penultimate hours of trade which pulled the index below 10,500 levels as well as 50-day moving average.

 
Trade and growth fears spark dash for safe havens

21h thehindubusinessline
The pan-European stock index meanwhile fell 0.8 per cent, while futures signalled a sharply weaker open for New York markets.

 
SEBI to auction properties, vehicles of Pancard next month

22h thehindubusinessline
Looking to recover over Rs 7,000 crore of investors’ money, the Securities and Exchange Board of India has put up for auction luxury vehicles and properties owned by Pancard Clubs.

 
Disappointed in UTI MF shareholders for not cutting down stakes: T Rowe Price

22h livemint
New Delhi: T Rowe Price, the largest stakeholder in UTI Mutual Fund, has said it is disappointed in the Indian shareholders for not taking steps to bring down their stakes to 10% in order to comply with Securities and Exchange Board of India’s (Sebi) directive.

 
Will pursue new types of financial listings: NYSE’s first woman prez

23h thehindubusinessline
Stacey Cunningham, who is set to become the first woman president of the New York Stock Exchange, has said that she would pursue new types of financial listings and work to reverse the decline of international public offerings.

 
Fuel subsidy sharing woes: OMCs, refiners top percentage losers on NSE

23h thehindubusinessline
Oil marketing companies such as IOC, HPCL and BPCL fell as much as 4.8 per cent to 7 per cent as according to Moody’s Investors Service, state-run explorers face increasing risk of sharing fuel subsidy.

 
Market Update: PSU banks rally led by SBI, Andhra Bank; HPCL, BPCL fall 4%

23h moneycontrol
The market is trading on a negative note this Wednesday afternoon, with the Nifty down 21 points at 10,514 and the Sensex down 19 points at 34,631.

 
NSE issues show-cause notice to UB Holdings, 15 others for delisting of shares

2018-05-23 thehindubusinessline
Leading stock exchange NSE has issued a show-cause notice to defaulter businessman Vijay Mallya-led UB (Holdings) for delisting of its shares as trading has been suspended for a long time due to regulatory non-compliance.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

CUSIP: 856121108